ZELVYSIA

Sapropterin dihydrochloride · Aucta Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZELVYSIA, covering 2025-04-29 to 2025-04-29. Get the full timeline:

Most recent: FDA Approved: ZELVYSIA — Original Application (Aucta Pharmaceuticals, Inc.)